These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36320276)

  • 1. Self-fused concatenation of interferon with enhanced bioactivity, pharmacokinetics and antitumor efficacy.
    Hu J; Shi J; Yuan Y; Li S; Zhang B; Dong H; Zhong Q; Xie Q; Bai X; Li Y
    RSC Adv; 2022 Sep; 12(43):28279-28282. PubMed ID: 36320276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of bioactivity, thermal stability and tumor retention by self-fused concatenation of green fluorescent protein.
    Hu J; Shi J; Yuan Y; Zhang B; Li S; Dong H
    Biochem Biophys Rep; 2021 Dec; 28():101112. PubMed ID: 34485712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-tail macrocyclization of albumin-binding domain fused interferon alpha improves the stability, activity, tumor penetration, and pharmacology.
    Guo J; Sun J; Liu X; Wang Z; Gao W
    Biomaterials; 2020 Aug; 250():120073. PubMed ID: 32353628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of human IFN-beta complex with the soluble type I interferon receptor IFNAR-2 leads to enhanced IFN stability, pharmacokinetics, and antitumor activity in xenografted SCID mice.
    McKenna SD; Vergilis K; Arulanandam AR; Weiser WY; Nabioullin R; Tepper MA
    J Interferon Cytokine Res; 2004 Feb; 24(2):119-29. PubMed ID: 14980076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b.
    Lee JI; Eisenberg SP; Rosendahl MS; Chlipala EA; Brown JD; Doherty DH; Cox GN
    J Interferon Cytokine Res; 2013 Dec; 33(12):769-77. PubMed ID: 23962003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridine-2,6-dicarboxaldehyde-Enabled N-Terminal In Situ Growth of Polymer-Interferon α Conjugates with Significantly Improved Pharmacokinetics and In Vivo Bioactivity.
    Sun J; Liu X; Guo J; Zhao W; Gao W
    ACS Appl Mater Interfaces; 2021 Jan; 13(1):88-96. PubMed ID: 33382581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics.
    Jo YW; Youn YS; Lee SH; Kim BM; Kang SH; Yoo M; Choi EC; Lee KC
    Int J Pharm; 2006 Feb; 309(1-2):87-93. PubMed ID: 16406701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Highly Bioactive Lys-Deficient IFN Leads to a Site-Specific Di-PEGylated IFN with Equivalent Bioactivity to That of Unmodified IFN-α2b.
    Imada T; Moriya K; Uchiyama M; Inukai N; Hitotsuyanagi M; Masuda A; Suzuki T; Ayukawa S; Tagawa YI; Dohmae N; Kohara M; Yamamura M; Kiga D
    ACS Synth Biol; 2018 Nov; 7(11):2537-2546. PubMed ID: 30277749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics Versus In Vitro Antiproliferative Potency to Design a Novel Hyperglycosylated hIFN-α2 Biobetter.
    Gugliotta A; Leopold MJ; Mufarrege E; Etcheverrigaray M; Kratje R; Ceaglio N; Oggero M
    Pharm Res; 2021 Jan; 38(1):37-50. PubMed ID: 33443683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing Pharmacokinetics, Tumor Accumulation, and Antitumor Efficacy by Elastin-Like Polypeptide Fusion of Interferon Alpha.
    Hu J; Wang G; Liu X; Gao W
    Adv Mater; 2015 Dec; 27(45):7320-4. PubMed ID: 26463662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
    Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concatenated alignments and the case of the disappearing tree.
    Thiergart T; Landan G; Martin WF
    BMC Evol Biol; 2014 Dec; 14():266. PubMed ID: 25547755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal combination of thermosensitive polypeptide fused interferon and temozolomide for post-surgical glioblastoma immunochemotherapy.
    Liang P; Wang G; Liu X; Wang Z; Wang J; Gao W
    Biomaterials; 2021 Jan; 264():120447. PubMed ID: 33069137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin fusion improves the pharmacokinetics and in vivo antitumor efficacy of canine interferon gamma.
    Li B; Chen A; Zou S; Wu J; Wang H; Chen R; Luo M
    Int J Pharm; 2019 Mar; 558():404-412. PubMed ID: 30639219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunit.
    Ceaglio N; Gugliotta A; Tardivo MB; Cravero D; Etcheverrigaray M; Kratje R; Oggero M
    J Biotechnol; 2016 Mar; 221():13-24. PubMed ID: 26806490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concatenation of Transgenic DNA: Random or Orchestrated?
    Smirnov A; Battulin N
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous expression of concatenated nicotinic ACh receptors: Pros and cons of subunit concatenation and recommendations for construct designs.
    Liao VWY; Kusay AS; Balle T; Ahring PK
    Br J Pharmacol; 2020 Sep; 177(18):4275-4295. PubMed ID: 32627170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior Antitumor Efficacy of IFN-α2b-Incorporated Photo-Cross-Linked Hydrogels Combined with T Cell Transfer and Low-Dose Irradiation Against Gastric Cancer.
    Liu Q; Zhang D; Qian H; Chu Y; Yang Y; Shao J; Xu Q; Liu B
    Int J Nanomedicine; 2020; 15():3669-3680. PubMed ID: 32547021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice.
    van der Voort LF; Kok A; Visser A; Oudejans CB; Caldano M; Gilli F; Bertolotto A; Polman CH; Killestein J
    Mult Scler; 2009 Feb; 15(2):212-8. PubMed ID: 18805837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
    Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
    Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.